Chain

Severe RSV disease remains a serious threat

Recent studies show a trend in increased RSV hospitalizations and complications among high-risk infants¹⁻⁴

Sentinel1 study:

A study of preterm infants 29-35 wGA hospitalized with laboratory-confirmed RSV during the 2014-2015 and 2015-2016 RSV seasons1


Kong et al study:

A study of hospitalization rates in commercially insured and Medicaid-insured preterm and full-term infants across the 2013-2014 and 2014-2015 RSV seasons2

Goldstein et al study:

A study of RSV hospitalization risks in commercially insured and Medicaid-insured infants <29 wGA vs full-term infants since 2014³

Friedman et al study:

A 2016 study of RSV hospitalization, mechanical ventilation, and inpatient mortality among children with specific CHD diagnoses during their second year of life4

References

  1. Anderson EJ, DeVincenzo JP, Checchia PA, et al [poster #1279]. Presented at: IDWeek; October 26-30, 2016; New Orleans, LA.

  2. Kong AM, Krilov LR, Fergie J, et al. Am J Perinatol. 2018;35(02):192-200.

  3. Friedman D, Fryzek J, Jiang X, et al. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS One. 2017;12(3):e0172512. doi:10.1371/journal.pone.0172512.

Severe RSV disease remains a serious threat

Recent studies show a trend in increased RSV hospitalizations and complications among high-risk infants¹⁻⁴

Sentinel1 study:

A study of preterm infants 29-35 wGA hospitalized with laboratory-confirmed RSV during the 2014-2015 and 2015-2016 RSV seasons1


Kong et al study:

A study of hospitalization rates in commercially insured and Medicaid-insured preterm and full-term infants across the 2013-2014 and 2014-2015 RSV seasons2

Goldstein et al study:

A study of RSV hospitalization risks in commercially insured and Medicaid-insured infants <29 wGA vs full-term infants since 2014³

Friedman et al study:

A 2016 study of RSV hospitalization, mechanical ventilation, and inpatient mortality among children with specific CHD diagnoses during their second year of life4

References

  1. Anderson EJ, DeVincenzo JP, Checchia PA, et al [poster #1279]. Presented at: IDWeek; October 26-30, 2016; New Orleans, LA.

  2. Kong AM, Krilov LR, Fergie J, et al. Am J Perinatol. 2018;35(02):192-200.

  3. Friedman D, Fryzek J, Jiang X, et al. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS One. 2017;12(3):e0172512. doi:10.1371/journal.pone.0172512.